Active, Not Recruiting
Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC
NCT03769103
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +15 more
- Locations
-
- BC Cancer, Vancouver Centre Vancouver, British Columbia, Canada
- Princess Margaret Hospital Toronto, Ontario, Canada
- Sunnybrook Health Sciences Centre Toronto, Ontario, Canada